1. 488PRandomized trial of prophylactic minocycline for erlotinib-associated skin rash in non-small cell lung cancer (PEARL trial). (24th November 2019) Authors: Kusaka, K; Tamura, A; Kozuki, T; Koreeda, Y; Kita, T; Endo, T; Shibayama, T; Hatakeyama, N; Miura, M; Yamashita, N; Takenoyama, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LBA65IMpower131: Progression-free survival (PFS) and overall survival (OS) analysis of a randomised phase III study of atezolizumab + carboplatin + paclitaxel or nab-paclitaxel vs carboplatin + nab-paclitaxel in 1L advanced squamous NSCLC. (23rd October 2018) Authors: Socinski, M A; Rittmeyer, A; Shapovalov, D; Orlandi, F; McCleod, M; Soo, R A; Palmero, R; Kozuki, T; Migliorino, M R; Koynov, K D; Berard, H; Hughes, B G M; Yu, W; Graupner, V; Sun, S W; Kowanetz, M; Hoang, T; Lin, W; Jotte, R M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗